Signaling pathway discoveries suggest ways to induce stem cells to become cardiac muscle cells, which could be useful for regenerating damaged heart muscle.

Brain deficits are not present in the early stages of schizophrenia, suggesting it may be possible to delay or prevent the development of brain abnormalities.

New details about the life cycle of respiratory syncytial virus (RSV) could aid the development of therapies to combat this leading cause of serious illness in infants and the elderly.

ResearchMatch.org is a web-based registry that is connecting participants and researchers for clinical studies.

A new analytical tool points to genes that act together to increase disease risk.

Treatment with a drug used to prevent organ rejection partially reverses the course of tuberous sclerosis, research in mice suggests.

Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.